Urovant Sciences Ltd. Financial Statements 2011-2024 | UROV

Annual Financial Statements Urovant Sciences Ltd.

	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	273 B	176 B	-	-	-	-	-	-	-	-
Shares	30.4 B	23.5 B	-	-	-	-	-	-	-	-
Net Income	-147 M	-111 M	-37.1 M	-27 M	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-
EBITDA	-143 M	-111 M	-37 M	-27.1 M	-	-	-	-	-	-
Operating Expenses	139 M	111 M	-	-	-	-	-	-	-	-
General and Administrative Expenses	46.3 M	18.6 M	4.64 M	1.02 M	-	-	-	-	-	-

All numbers in USD currency